APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Injections for SMA

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Injections for SMA Market Analysis and Forecast 2026-2032

Report ID 174003350229 December 2025198 pages

Choose your research edition.

Industry ResearchInjections for SMA Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Injections for SMA Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Injections for SMA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Injections for SMA Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Injections for SMA Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Injections for SMA market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Injections for SMA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Injections for SMA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Injections for SMA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Injections for SMA is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Injections for SMA include Novartis, Biogen and Ionis Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Injections for SMA, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Injections for SMA, also provides the sales of main regions and countries. Of the upcoming market potential for Injections for SMA, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Injections for SMA sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Injections for SMA market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Injections for SMA sales, projected growth trends, production technology, application and end-user industry.

Injections for SMA Segment by Company

Novartis

Biogen

Ionis Pharmaceuticals

Injections for SMA Segment by Type

Antisense Oligonucleotides

Gene Therapy

Injections for SMA Segment by Application

Hospital

Clinic

Other

Injections for SMA Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injections for SMA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injections for SMA and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injections for SMA.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Injections for SMA in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Injections for SMA manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injections for SMA sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Injections for SMA Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antisense Oligonucleotides Major Manufacturers Table 3. Gene Therapy Major Manufacturers Table 4. Global Injections for SMA Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Injections for SMA Industry Trends Table 9. Injections for SMA Industry Drivers Table 10. Injections for SMA Industry Opportunities and Challenges Table 11. Injections for SMA Industry Restraints Table 12. Global Injections for SMA Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Injections for SMA Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Injections for SMA Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Injections for SMA Revenue Market Share by Region (2021-2026) Table 16. Global Injections for SMA Revenue Market Share by Region (2027-2032) Table 17. Global Injections for SMA Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Injections for SMA Sales by Region (2021-2026) & (K Units) Table 19. Global Injections for SMA Sales by Region (2027-2032) & (K Units) Table 20. Global Injections for SMA Sales Market Share by Region (2021-2026) Table 21. Global Injections for SMA Sales Market Share by Region (2027-2032) Table 22. Global Injections for SMA Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Injections for SMA Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Injections for SMA Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Injections for SMA Sales Market Share by Manufacturers (2021-2026) Table 26. Global Injections for SMA Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Injections for SMA Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Injections for SMA Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Injections for SMA Manufacturers, Product Type & Application Table 30. Global Injections for SMA Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Injections for SMA by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Injections for SMA Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Injections for SMA Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Injections for SMA Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Injections for SMA Revenue Market Share by Type (2021-2026) Table 37. Global Injections for SMA Revenue Market Share by Type (2027-2032) Table 38. Global Injections for SMA Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Injections for SMA Sales by Type (2021-2026) & (K Units) Table 40. Global Injections for SMA Sales by Type (2027-2032) & (K Units) Table 41. Global Injections for SMA Sales Market Share by Type (2021-2026) Table 42. Global Injections for SMA Sales Market Share by Type (2027-2032) Table 43. Global Injections for SMA Price by Type (2021-2026) & (US$/Unit) Table 44. Global Injections for SMA Price by Type (2027-2032) & (US$/Unit) Table 45. Global Injections for SMA Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Injections for SMA Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Injections for SMA Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Injections for SMA Revenue Market Share by Application (2021-2026) Table 49. Global Injections for SMA Revenue Market Share by Application (2027-2032) Table 50. Global Injections for SMA Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Injections for SMA Sales by Application (2021-2026) & (K Units) Table 52. Global Injections for SMA Sales by Application (2027-2032) & (K Units) Table 53. Global Injections for SMA Sales Market Share by Application (2021-2026) Table 54. Global Injections for SMA Sales Market Share by Application (2027-2032) Table 55. Global Injections for SMA Price by Application (2021-2026) & (US$/Unit) Table 56. Global Injections for SMA Price by Application (2027-2032) & (US$/Unit) Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Novartis Injections for SMA Product Portfolio Table 61. Novartis Recent Development Table 62. Biogen Company Information Table 63. Biogen Business Overview Table 64. Biogen Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Biogen Injections for SMA Product Portfolio Table 66. Biogen Recent Development Table 67. Ionis Pharmaceuticals Company Information Table 68. Ionis Pharmaceuticals Business Overview Table 69. Ionis Pharmaceuticals Injections for SMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Ionis Pharmaceuticals Injections for SMA Product Portfolio Table 71. Ionis Pharmaceuticals Recent Development Table 72. North America Injections for SMA Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Injections for SMA Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Injections for SMA Sales by Type (2021-2026) & (K Units) Table 75. North America Injections for SMA Sales by Type (2027-2032) & (K Units) Table 76. North America Injections for SMA Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Injections for SMA Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Injections for SMA Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Injections for SMA Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Injections for SMA Sales by Application (2021-2026) & (K Units) Table 81. North America Injections for SMA Sales by Application (2027-2032) & (K Units) Table 82. North America Injections for SMA Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Injections for SMA Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Injections for SMA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Injections for SMA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Injections for SMA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Injections for SMA Sales by Country (2021-2026) & (K Units) Table 89. North America Injections for SMA Sales by Country (2027-2032) & (K Units) Table 90. North America Injections for SMA Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Injections for SMA Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Injections for SMA Revenue (2021-2032) & (US$ Million) Table 93. Canada Injections for SMA Revenue (2021-2032) & (US$ Million) Table 94. Mexico Injections for SMA Revenue (2021-2032) & (US$ Million) Table 95. Europe Injections for SMA Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Injections for SMA Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Injections for SMA Sales by Type (2021-2026) & (K Units) Table 98. Europe Injections for SMA Sales by Type (2027-2032) & (K Units) Table 99. Europe Injections for SMA Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Injections for SMA Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Injections for SMA Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Injections for SMA Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Injections for SMA Sales by Application (2021-2026) & (K Units) Table 104. Europe Injections for SMA Sales by Application (2027-2032) & (K Units) Table 105. Europe Injections for SMA Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Injections for SMA Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Injections for SMA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Injections for SMA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Injections for SMA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Injections for SMA Sales by Country (2021-2026) & (K Units) Table 112. Europe Injections for SMA Sales by Country (2027-2032) & (K Units) Table 113. Europe Injections for SMA Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Injections for SMA Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Injections for SMA Revenue (2021-2032) & (US$ Million) Table 116. France Injections for SMA Revenue (2021-2032) & (US$ Million) Table 117. U.K. Injections for SMA Revenue (2021-2032) & (US$ Million) Table 118. Italy Injections for SMA Revenue (2021-2032) & (US$ Million) Table 119. Russia Injections for SMA Revenue (2021-2032) & (US$ Million) Table 120. Spain Injections for SMA Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Injections for SMA Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Injections for SMA Revenue (2021-2032) & (US$ Million) Table 123. Sweden Injections for SMA Revenue (2021-2032) & (US$ Million) Table 124. Poland Injections for SMA Revenue (2021-2032) & (US$ Million) Table 125. China Injections for SMA Revenue by Type (2021-2026) & (US$ Million) Table 126. China Injections for SMA Revenue by Type (2027-2032) & (US$ Million) Table 127. China Injections for SMA Sales by Type (2021-2026) & (K Units) Table 128. China Injections for SMA Sales by Type (2027-2032) & (K Units) Table 129. China Injections for SMA Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Injections for SMA Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Injections for SMA Revenue by Application (2021-2026) & (US$ Million) Table 132. China Injections for SMA Revenue by Application (2027-2032) & (US$ Million) Table 133. China Injections for SMA Sales by Application (2021-2026) & (K Units) Table 134. China Injections for SMA Sales by Application (2027-2032) & (K Units) Table 135. China Injections for SMA Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Injections for SMA Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Injections for SMA Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Injections for SMA Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Injections for SMA Sales by Type (2021-2026) & (K Units) Table 140. Asia Injections for SMA Sales by Type (2027-2032) & (K Units) Table 141. Asia Injections for SMA Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Injections for SMA Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Injections for SMA Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Injections for SMA Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Injections for SMA Sales by Application (2021-2026) & (K Units) Table 146. Asia Injections for SMA Sales by Application (2027-2032) & (K Units) Table 147. Asia Injections for SMA Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Injections for SMA Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Injections for SMA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Injections for SMA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Injections for SMA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Injections for SMA Sales by Country (2021-2026) & (K Units) Table 154. Asia Injections for SMA Sales by Country (2027-2032) & (K Units) Table 155. Asia Injections for SMA Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Injections for SMA Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Injections for SMA Revenue (2021-2032) & (US$ Million) Table 158. South Korea Injections for SMA Revenue (2021-2032) & (US$ Million) Table 159. India Injections for SMA Revenue (2021-2032) & (US$ Million) Table 160. Australia Injections for SMA Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Injections for SMA Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Injections for SMA Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Injections for SMA Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Injections for SMA Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Injections for SMA Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Injections for SMA Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Injections for SMA Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Injections for SMA Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Injections for SMA Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Injections for SMA Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Injections for SMA Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Injections for SMA Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Injections for SMA Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Injections for SMA Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Injections for SMA Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Injections for SMA Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Injections for SMA Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Injections for SMA Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Injections for SMA Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Injections for SMA Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Injections for SMA Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Injections for SMA Revenue (2021-2032) & (US$ Million) Table 184. Argentina Injections for SMA Revenue (2021-2032) & (US$ Million) Table 185. Chile Injections for SMA Revenue (2021-2032) & (US$ Million) Table 186. Colombia Injections for SMA Revenue (2021-2032) & (US$ Million) Table 187. Peru Injections for SMA Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Injections for SMA Revenue (2021-2032) & (US$ Million) Table 189. Israel Injections for SMA Revenue (2021-2032) & (US$ Million) Table 190. UAE Injections for SMA Revenue (2021-2032) & (US$ Million) Table 191. Turkey Injections for SMA Revenue (2021-2032) & (US$ Million) Table 192. Iran Injections for SMA Revenue (2021-2032) & (US$ Million) Table 193. Egypt Injections for SMA Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Injections for SMA Distributors List Table 197. Injections for SMA Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Injections for SMA Image Figure 2. Global Injections for SMA Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injections for SMA Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antisense Oligonucleotides Image Figure 5. Gene Therapy Image Figure 6. Global Injections for SMA Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Injections for SMA Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Injections for SMA Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Injections for SMA Revenue (2021-2032) & (US$ Million) Figure 13. Global Injections for SMA Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Injections for SMA Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Injections for SMA Revenue Market Share by Region (2021-2032) Figure 16. Global Injections for SMA Sales (2021-2032) & (K Units) Figure 17. Global Injections for SMA Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Injections for SMA Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Injections for SMA Sales YoY (2021-2032) & (K Units) Figure 20. Europe Injections for SMA Sales YoY (2021-2032) & (K Units) Figure 21. China Injections for SMA Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Injections for SMA Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Injections for SMA Sales YoY (2021-2032) & (K Units) Figure 24. Global Injections for SMA Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Injections for SMA Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Injections for SMA Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Injections for SMA Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Injections for SMA Revenue Market Share by Type (2021-2032) Figure 30. Global Injections for SMA Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Injections for SMA Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Injections for SMA Sales Market Share by Type (2021-2032) Figure 33. Global Injections for SMA Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Injections for SMA Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Injections for SMA Revenue Market Share by Application (2021-2032) Figure 36. Global Injections for SMA Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Injections for SMA Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Injections for SMA Sales Market Share by Application (2021-2032) Figure 39. North America Injections for SMA Revenue Share by Type (2021-2032) Figure 40. North America Injections for SMA Sales Share by Type (2021-2032) Figure 41. North America Injections for SMA Revenue Share by Application (2021-2032) Figure 42. North America Injections for SMA Sales Share by Application (2021-2032) Figure 43. North America Injections for SMA Revenue Share by Country (2021-2032) Figure 44. North America Injections for SMA Sales Share by Country (2021-2032) Figure 45. Europe Injections for SMA Revenue Share by Type (2021-2032) Figure 46. Europe Injections for SMA Sales Share by Type (2021-2032) Figure 47. Europe Injections for SMA Revenue Share by Application (2021-2032) Figure 48. Europe Injections for SMA Sales Share by Application (2021-2032) Figure 49. Europe Injections for SMA Revenue Share by Country (2021-2032) Figure 50. Europe Injections for SMA Sales Share by Country (2021-2032) Figure 51. China Injections for SMA Revenue Share by Type (2021-2032) Figure 52. China Injections for SMA Sales Share by Type (2021-2032) Figure 53. China Injections for SMA Revenue Share by Application (2021-2032) Figure 54. China Injections for SMA Sales Share by Application (2021-2032) Figure 55. Asia Injections for SMA Revenue Share by Type (2021-2032) Figure 56. Asia Injections for SMA Sales Share by Type (2021-2032) Figure 57. Asia Injections for SMA Revenue Share by Application (2021-2032) Figure 58. Asia Injections for SMA Sales Share by Application (2021-2032) Figure 59. Asia Injections for SMA Revenue Share by Country (2021-2032) Figure 60. Asia Injections for SMA Sales Share by Country (2021-2032) Figure 61. SAMEA Injections for SMA Revenue Share by Type (2021-2032) Figure 62. SAMEA Injections for SMA Sales Share by Type (2021-2032) Figure 63. SAMEA Injections for SMA Revenue Share by Application (2021-2032) Figure 64. SAMEA Injections for SMA Sales Share by Application (2021-2032) Figure 65. SAMEA Injections for SMA Revenue Share by Country (2021-2032) Figure 66. SAMEA Injections for SMA Sales Share by Country (2021-2032) Figure 67. Injections for SMA Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Injections for SMA Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Antisense Oligonucleotides
  • Gene Therapy
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Biogen
  • Ionis Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Injections for SMA Market by Type
  3. 1.2.1 Global Injections for SMA Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antisense Oligonucleotides
  5. 1.2.3 Gene Therapy
  6. 1.3 Injections for SMA Market by Application
  7. 1.3.1 Global Injections for SMA Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Injections for SMA Market Dynamics
  1. 2.1 Injections for SMA Industry Trends
  2. 2.2 Injections for SMA Industry Drivers
  3. 2.3 Injections for SMA Industry Opportunities and Challenges
  4. 2.4 Injections for SMA Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Injections for SMA Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Injections for SMA Revenue by Region
  3. 3.2.1 Global Injections for SMA Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Injections for SMA Revenue by Region (2021-2026)
  5. 3.2.3 Global Injections for SMA Revenue by Region (2027-2032)
  6. 3.2.4 Global Injections for SMA Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Injections for SMA Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Injections for SMA Sales by Region
  9. 3.4.1 Global Injections for SMA Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Injections for SMA Sales by Region (2021-2026)
  11. 3.4.3 Global Injections for SMA Sales by Region (2027-2032)
  12. 3.4.4 Global Injections for SMA Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Injections for SMA Revenue by Manufacturers
  2. 4.1.1 Global Injections for SMA Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Injections for SMA Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Injections for SMA Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Injections for SMA Sales by Manufacturers
  6. 4.2.1 Global Injections for SMA Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Injections for SMA Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Injections for SMA Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Injections for SMA Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Injections for SMA Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Injections for SMA Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Injections for SMA Manufacturers, Product Type & Application
  13. 4.7 Global Injections for SMA Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Injections for SMA Market CR5 and HHI
  16. 4.8.2 2025 Injections for SMA Tier 1, Tier 2, and Tier 3
5 Injections for SMA Market by Type
  1. 5.1 Global Injections for SMA Revenue by Type
  2. 5.1.1 Global Injections for SMA Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Injections for SMA Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Injections for SMA Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Injections for SMA Sales by Type
  6. 5.2.1 Global Injections for SMA Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injections for SMA Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Injections for SMA Sales Market Share by Type (2021-2032)
  9. 5.3 Global Injections for SMA Price by Type
6 Injections for SMA Market by Application
  1. 6.1 Global Injections for SMA Revenue by Application
  2. 6.1.1 Global Injections for SMA Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Injections for SMA Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Injections for SMA Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Injections for SMA Sales by Application
  6. 6.2.1 Global Injections for SMA Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Injections for SMA Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Injections for SMA Sales Market Share by Application (2021-2032)
  9. 6.3 Global Injections for SMA Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Injections for SMA Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Injections for SMA Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Biogen
  8. 7.2.1 Biogen Company Information
  9. 7.2.2 Biogen Business Overview
  10. 7.2.3 Biogen Injections for SMA Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biogen Injections for SMA Product Portfolio
  12. 7.2.5 Biogen Recent Developments
  13. 7.3 Ionis Pharmaceuticals
  14. 7.3.1 Ionis Pharmaceuticals Company Information
  15. 7.3.2 Ionis Pharmaceuticals Business Overview
  16. 7.3.3 Ionis Pharmaceuticals Injections for SMA Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ionis Pharmaceuticals Injections for SMA Product Portfolio
  18. 7.3.5 Ionis Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Injections for SMA Market Size by Type
  2. 8.1.1 North America Injections for SMA Revenue by Type (2021-2032)
  3. 8.1.2 North America Injections for SMA Sales by Type (2021-2032)
  4. 8.1.3 North America Injections for SMA Price by Type (2021-2032)
  5. 8.2 North America Injections for SMA Market Size by Application
  6. 8.2.1 North America Injections for SMA Revenue by Application (2021-2032)
  7. 8.2.2 North America Injections for SMA Sales by Application (2021-2032)
  8. 8.2.3 North America Injections for SMA Price by Application (2021-2032)
  9. 8.3 North America Injections for SMA Market Size by Country
  10. 8.3.1 North America Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Injections for SMA Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Injections for SMA Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Injections for SMA Market Size by Type
  2. 9.1.1 Europe Injections for SMA Revenue by Type (2021-2032)
  3. 9.1.2 Europe Injections for SMA Sales by Type (2021-2032)
  4. 9.1.3 Europe Injections for SMA Price by Type (2021-2032)
  5. 9.2 Europe Injections for SMA Market Size by Application
  6. 9.2.1 Europe Injections for SMA Revenue by Application (2021-2032)
  7. 9.2.2 Europe Injections for SMA Sales by Application (2021-2032)
  8. 9.2.3 Europe Injections for SMA Price by Application (2021-2032)
  9. 9.3 Europe Injections for SMA Market Size by Country
  10. 9.3.1 Europe Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Injections for SMA Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Injections for SMA Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Injections for SMA Market Size by Type
  2. 10.1.1 China Injections for SMA Revenue by Type (2021-2032)
  3. 10.1.2 China Injections for SMA Sales by Type (2021-2032)
  4. 10.1.3 China Injections for SMA Price by Type (2021-2032)
  5. 10.2 China Injections for SMA Market Size by Application
  6. 10.2.1 China Injections for SMA Revenue by Application (2021-2032)
  7. 10.2.2 China Injections for SMA Sales by Application (2021-2032)
  8. 10.2.3 China Injections for SMA Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Injections for SMA Market Size by Type
  2. 11.1.1 Asia Injections for SMA Revenue by Type (2021-2032)
  3. 11.1.2 Asia Injections for SMA Sales by Type (2021-2032)
  4. 11.1.3 Asia Injections for SMA Price by Type (2021-2032)
  5. 11.2 Asia Injections for SMA Market Size by Application
  6. 11.2.1 Asia Injections for SMA Revenue by Application (2021-2032)
  7. 11.2.2 Asia Injections for SMA Sales by Application (2021-2032)
  8. 11.2.3 Asia Injections for SMA Price by Application (2021-2032)
  9. 11.3 Asia Injections for SMA Market Size by Country
  10. 11.3.1 Asia Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Injections for SMA Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Injections for SMA Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Injections for SMA Market Size by Type
  2. 12.1.1 SAMEA Injections for SMA Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Injections for SMA Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Injections for SMA Price by Type (2021-2032)
  5. 12.2 SAMEA Injections for SMA Market Size by Application
  6. 12.2.1 SAMEA Injections for SMA Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Injections for SMA Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Injections for SMA Price by Application (2021-2032)
  9. 12.3 SAMEA Injections for SMA Market Size by Country
  10. 12.3.1 SAMEA Injections for SMA Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Injections for SMA Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Injections for SMA Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Injections for SMA Value Chain Analysis
  2. 13.1.1 Injections for SMA Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Injections for SMA Production Mode & Process
  6. 13.2 Injections for SMA Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Injections for SMA Distributors
  9. 13.2.3 Injections for SMA Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst